Neogenomics (NEO) Announces Quarterly Results
Neogenomics (NYSE:NEO) released its earnings data on Wednesday. The company reported $0.02 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.01 by $0.01, American Banking & Market News reports. The company had revenue of $16.90 million for the quarter, compared to the consensus estimate of $16.84 million.
Neogenomics (NYSE:NEO) opened at 2.99 on Wednesday. Neogenomics has a 1-year low of $2.05 and a 1-year high of $4.20. The stock has a 50-day moving average of $2.49 and a 200-day moving average of $3.41. The company’s market cap is $146.2 million.
NeoGenomics, Inc (NYSE:NEO) operates a network of cancer-focused testing laboratories.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.